Suchergebnisse - "Catharina Gerhards"

PubPharm (9)

1

The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant

in: Vaccines | 2024

von Catharina Gerhards | Marlene Steingass | Alexandra Heininger | +6

2

Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome

in: Viruses | 2023

von Catharina Gerhards | Maximilian Kittel | Volker Ast | +6

3

Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines

in: Vaccines | 2023

von Catharina Gerhards | Margot Thiaucourt | Michael Hetjens | +3

4

Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients

in: Microorganisms | 2023

von Catharina Gerhards | Verena Haselmann | Samuel F. Schaible | +7

5

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

in: Frontiers in Immunology | 2022

von Feyza Gül Özbay Kurt | Feyza Gül Özbay Kurt | Feyza Gül Özbay Kurt | +34

6

Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions

in: Life | 2022

von Frederic Jungbauer | Catharina Gerhards | Margot Thiaucourt | +6

7

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection

in: International Journal of Infectious Diseases | 2021

von Catharina Gerhards | Margot Thiaucourt | Maximilian Kittel | +5

8

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay

in: International Journal of Infectious Diseases | 2021

von Maximilian Kittel | Peter Findeisen | Maria-Christina Muth | +4

9

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays

in: International Journal of Infectious Diseases | 2021

von Maximilian Kittel | Maria Christina Muth | Ingrid Zahn | +6

1
[1]